Adolescent depression: Controlled desipramine treatment and atypical features

Depression and Anxiety

Volumn 7, Issue 1, 1998, Pages 15-31

  Klein, Rachel G ^a   Mannuzza, Salvatore ^a,b   Koplewicz, Harold S ^c   Tancer, Nancy K ^d   Shah, Manoj ^b   Liang, Vera ^d   Davies, Mark ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NONE

Author keywords

Adolescent MDD; Atypical depression; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; CHILD BEHAVIOR; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SPECIFICITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MOOD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0031838372     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)7:1<15::AID-DA3>3.0.CO;2-4     Document Type: Article

References (69)

1. Ambrosini PJ, Bianchi MD, Rabinovich II, Elia J (1993) Antidepressant treatments in children and adolescents: I. Affective disorders. J Am Acad Child Adolesc Psychiatry 32:1-6.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Association.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association.
4. Asnis GM, McGinn LK, Sanderson WC (1995) Atypical depression: Clinical aspects and noradrenergic function. Am J Psychiatry 152:31-36.
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psyciatry 4:561-571.
6. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J (1996) Childhood and adolescent depression: A review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry 35:1575-1583.
7. Brent DA, Holder D, Kolko D, Birmaher B, Baugher M, Roth C, Iyengar S, Johnson BA (1997) A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 54:877-885.
8. Bruder GE, Quitkin FM, Stewart JW, Martin C, Voglmaier MM, Harrison W (1989) Cerebral laterality and depression: Perceptual asymmetry in diagnostic subtypes before and after antidepressant treatment. J Abnorm Psychology 98:177-186.
9. Chambers W, Puig-Antich J, Hirsch M, Paez P, Ambrosini P, Tabrizi M, Davies M (1985) The assessment of affective disorders in children and adolescents by semi-structured interview: Test-retest reliability of the K-SADS-P. Arch Gen Psychiatry 42-696-702.
10. Christie KA, Burke JD, Regier DA, Rae DS, Boyd JH, Locke BZ (1988) Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults. Am J Psychiatry 145:971-975.
11. Covi L, Lipman RS (1984) Primary depression or primary anxiety? A possible approach to a diagnostic dilemma. Clin Neuropharmacol 7.924-925.
12. Derogatis LR, Lipman RS, Covi L (1973) SCL-90: An outpatient psychiatric rating scale. Psychopharmacol Bull 9:13-28.
13. Derogatis LR, Lipman RS, Rickels K, Uhlemhuth EH, Covi L (1974) The Hopkins Symptom Checklist (HSCL): A self report symptom inventory. Behav Sci 19:1-15.
14. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J (1997) A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037.
15. Fairbanks J, Kentgen LM, Bearman K, Ma Y, Klein RG (October, 1997) Atypical depression in adolescents: test-retest and interrater reliability. Paper presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatty, Toronto, Canada.
16. Friedman RC, Hurt SW, Clarkin JF, Corn R, Aronoff MS (1983) Symptoms of depression among adolescents and young adults. J Affect Dis 5:37-43.
17. Freud A (1958) Adolescence. Psychoanal Study Child 13:255-278.
18. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM (1990) Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 26:85-90.
19. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, Psychopharmacology Research Branch, Rockville, Maryland.
20. Hamilton M (1967) Development of a rating scale for primary depressive illness. Soc Psychol 6:278-296
21. Harrington R, Fudge H, Rutter M, Pickles A, Hill J (1990) Adult outcomes of childhood and adolescent depression: I. Psychiatric status. Arch Gen Psychiatry 47:465-473.
22. Harrington R, Rutter M, Weissman M, Fudge H, Groothues C, Bredenkamp D, Pickles A, Rende R, Wickramaratne P (1997) Psychiatric disorders in the relatives of depressed probands: I. Comparison of prepubertal, adolescent and early adult onset cases. J Affect Disord 42:9-22.
23. John K, Gammon GD, Prusoff BA, Warner V (1987) The Social Adjustment Inventory for Children and Adolescents (SAICA): Testing of a new semi-structured interview (SAICA). J Am Acad Child Adolesc Psychiatry 26:898-911.
24. Kayser A, Robinson DS, Nies A, Howard D (1985) Response to phenelzine among depressed patients with features of hysteroid dysphoria. Am J Psychiatry 142:486-488.
25. Keller MB, Beardslee WR, Dorer DJ, Lavori PW, Samuelson H, Klerman GR (1986) Impact of seventy and chronicity of parental affective illness on adaptive functioning and psychopathology in children. Arch Gen Psychiatry 43:930-937.
26. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996) The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53:391-399.
27. Klein DF, Davis JM (1969) Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore, MD: Williams & Wilkins.
28. Klein DN, Clark DC, Dansky L, Margolis ET (1988) Dysthymia in offspring of parents with primary unipolar affective disorder. J Abnorm Psychology 97:265-274.
29. Kovacs M (1985) The Children's Depression Inventory (CDI). Psychopharmacol Bull 21:995-998.
30. Kramer A, Feguine R (1981) Clinical effects of amitriptyline in adolescent depression. J Am Acad Child Psychiatry 20:636-664.
31. Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C, Reed K (1994) Response to desipramine treatment in adolescent depression: A fixed-dose piacebo-controlled trial. J Am Acad Child Adolesc Psychiatry 33:686-694.
32. Kutcher S, Marton P (1991) Affective disorders in first-degree relatives of adolescent onset bipolars, unipolars, and normal controls. J Am Acad Child Adolesc Psychiatry 30:75-78.
33. Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, Dachille S (1996) A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry 35:1139-1144.
34. Laraia MT (1996) Current approaches to the psychopharmacologic treatment of depression in children and adolescents. JCAPN 9:15-26.
35. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P (1994) Major depression in community adolescents: Age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 33:809-818.
36. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA (1993) Adolescent psychopathology: I. Prevalnce and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 102:133-144.
37. Lewinsohn PM, Rohde P, Seeley JR (1995) Adolescent psychopathology: III. The clinical consequences of comorbidity. J Am Acad Child Adolesc Psychiatry 34:510-519.
38. Liebowitz MR, Gorman JM, Fyer AJ, Campeas R, Levin A, Sandberg D, Hollander E, Papp L, Goetz D (1988) Pharmacotherapy of social phobia: A placebo controlled comparison of phenelzine and atenolol. J Clin Psychiatry 49:252-257.
39. Mannuzza S, Klein RG (1987) Schedule for the Assessment of Conduct, Hyperactivity, Anxiety, Mood, and Psychoactive Substances. Children's Behavior Disorders Clinic, Long Island Jewish Medical Center, New Hyde Park, New York.
40. Mannuzza S, Klein RG, Bossler A, Malloy P, LaPadula M (1993) Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565-576.
41. McGinn LK, Asnis GM, Rubinson F. (1996) Biological and clinical validation of atypical depression. Psychiatry Res 60:191-198.
42. McGrath PJ, Stewart JW, Nunes E, Ocepek-Welikson K, Rabkin J, Quitkin FM, Klein DF (1993) A double-blind crossover trial comparing imipramine to phenelzine in treatment refractory depression. Am J Psychiatry 150:118-123.
43. Mitchell J, McCauley E, Burke PM, Moss SJ (1988) Phenomenology of depression in children and adolescents. J Am Acad Child Adolesc Psychiatry 27:12-20.
44. Orvaschel H, Walsh-Allis G, Ye W (1988) Psychopathology in children of parents with recurrent depression. J Abnorm Child Psychol 16:17-28.
45. Overall JE, Pfefferbaum B (1982) The Brief Psychiatry Rating Scale for Children. Psychopharmacol Bull 18:10-16.
46. Poznanski EO, Cook SC, Carrol BJ (1979) A depression rating scale for children. Pediatrics 64:442-450.
47. Poznanski EO, Freeman LN, Mokros HB (1985) Children's depression rating scale-revised (September 1984). Psychopharmacol Bull 21:979-989.
48. Quitkin FM, Harrison W, Stewart JW, McGrath PJ, Tricamo E, Wager SC, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF (1991) Response to phenelzine and imipramine in placebo nonresponders with atypical depression. Arch Gen Psychiatry 48:319-323.
49. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SC, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF (1990) Atypical depression, panic attacks, and response to imipramine and phenelzine: A replication. Arch Gen Psychiatry 47:935-941.
50. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF (1989) Phenelzine and imipramine in mood reactive depressives: Further delineation of the syndrome of atypical depression. Arch Gen Psychiatry 46:787-793.
51. Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, Davies M, Goetz R, Puig-Antich J (1985) Sleep of atypical depressives. J Affect Dis 8:61-67.
52. Quitkin FM, Stewart SW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG (1988) Phenelzine versus imipramine in the treatment of probable atypical depression: Defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145:306-311.
53. Rao U, Ryan ND, Birmaher B, Dahl RE, Williamson DE, Kaufman J, Rao R, Nelson B (1995) Unipolar depression in adolescents: Clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 34:566-578.
54. Rao U, Weissman MM, Martin JA, Hammond RW (1993) Childhood depression and risk of suicide: A preliminary report of a longitudinal study. J Am Acad Child Adolesc Psychiatry 32:21-27.
55. Rie HF. (1966) Depression in childhood: A survey of some pertinent contributions. J Am Acad Child Adolesc Psychiatry 5:653-685.
56. Ryan ND, Puig-Antich J (1998) Neurobiology of depression in children and adolescents. In Mouren-Simeoni MC, Klein RG (eds): Childhood Depressions: Facts and Perspectives. Paris: Expansion Scientifique Publishers, pp. 215-223.
57. Ryan ND, Puig-Antich J, Ambrosini P, Rabinovich H, Robinson D, Nelson B, Iyengar S, Twomey J (1987) The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 44:854-861.
58. Sargant W (1962) The treatment of anxiety states and atypical depression by the monoamine oxidase inhibitor drugs. J Neuropsychiatry 3 (Suppl 596).
59. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S (1983) A children's global assessment scale (C-GAS). Arch Gen Psychiatry 40:1228-1231.
60. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S (1985) A children's global assessment scale (CGAS) (for children 4 to 16 years of age). Psychopharmacol Bull 21:747-748.
61. Simeon J (1990) Adolescent depression: A placebo controlled fluoxetine treatment study. Prog Neuropsychopharmacol Biol Psychiatry 14:791-795.
62. Stewart JW, McGrath PJ, Rabkin JG, Quitkin FM (1993) Atypical depression: A valid clinical entity? Psychiat Clin North Am 16:479-495.
63. Strober M, Lampert C, Schmidt S, Morrell W (1993) The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 32:34-42.
64. Thase ME, Frank E, Mallinger AG, Hamer T, Kupfer DJ (1992) Treatment of imipramme-resistant recurrent depression. III: efficacy of monoamine oxidase inhibitors. J Clin Psychiatry 53.5-11.
65. Warner V, Mufson L, Weissman MM (1995) Offspring at high and low risk for depression and anxiety: Mechanisms of psychiatric disorder. J Am Acad Child Adolesc Psychiatry 34:786-797.
66. Weinberg WA, Emslie GJ (1988) Weinberg Screening Affective Scale (WSAS and WSASSF). J Child Neurol 3:294-296.
67. Weissman MM, Warner V, Wickramaratne P, Prusoff BA (1988) Early-onset major depression in parents and their children. J Affect Disord 15:269-277.
68. West ED, Dally PJ (1959) Effect of iproniazid in depressive syndromes. Br Med J 1:1491-1494.
69. Williamsom DE, Ryan ND, Birmaher B, Dahl RE, Kaufman J, Rao U, Puig-Antich J (1995) A case-control family history study of depression in adolescents. J Am Acad Child Adolesc Psychiatry 34:1596-1607.